Stockreport

CytomX Therapeutics (CTMX) Making Progress on Key Metastatic Colorectal Cancer Treatment [Yahoo! Finance]

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com
PDF an Overweight rating on CytomX Therapeutics, Inc. (NASDAQ:CTMX) and increased the price target to $12 from $10. CytomX Therapeutics, Inc. (CTMX) Making Progress on Key [Read more]